Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.6000 (1.17%) ($147.9500 - $150.7400) on Tue. May. 3, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.6% (three month average) | RSI | 28 | Latest Price | $149.6000(1.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.9% a day on average for past five trading days. | Weekly Trend | ABBV declines -2.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(40%) SPLV(32%) DIA(30%) VYM(29%) XLP(29%) | Factors Impacting ABBV price | ABBV will decline at least -0.8% in a week (0% probabilities). VIXM(-20%) UUP(-13%) TBT(-7%) UNG(-0%) VXX(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.8% (StdDev 1.6%) | Hourly BBV | 1.1 () | Intraday Trend | 0.2% | | | |
|
Resistance Level | $159.35 | 5 Day Moving Average | $151.66(-1.36%) | 10 Day Moving Average | $153.9(-2.79%) | 20 Day Moving Average | $159.35(-6.12%) | To recent high | -14.5% | To recent low | 6.4% | Market Cap | $263.937b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |